Ion-Selective Electrode Methods Compared for Electrolytes
|
By LabMedica International staff writers Posted on 02 Jul 2019 |
|
Image: The RAPIDPoint 500 Blood Gas System delivers fast, accurate and comprehensive test results for whole blood samples in approximately 60 seconds (Photo courtesy of Siemens Healthineers).
Electrolytes are among the most commonly requested clinical laboratory tests. There are two methods for measuring electrolytes in plasma, both using the principle of an ion-selective electrode (ISE).
The first method, used in point-of-care blood gas analyzers, is direct potentiometry, which measures electrolyte activity in plasma without dilution. The second method, used in routine chemistry analyzers in central laboratories, is indirect ISE, which involves a pre-analytical serum or plasma dilution step.
Clinical biochemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues used anonymized laboratory results of patients admitted to the emergency room and intensive care unit, and demonstrated in four steps that this lack of interchangeability of sodium and chloride results can be attributed to differences in measurement principle, but also to analytical standardization issues of the blood gas analyzers.
The team extracted blood gas results performed on a RAPIDPoint 500 and routine chemistry performed on a Modular P800 sodium and chloride results for patients admitted to the emergency room of their hospital between June 1, 2014, and May 17, 2016.
The team investigated the effects of the introduction of the instrument factors in the blood gas analysers, by extracting blood gas and routine chemistry sodium and chloride results (with a maximum time of 1 hour between sample analysis) again for patients admitted to the emergency room of our hospital. This approach eliminated the systematic differences between blood gas and serum sodium for 92 emergency department patients, and reduced the mean difference in chloride to 1 mmol/L for 25 patients. The mean difference in sodium results between blood gas and serum for intensive care patients decreased from 4 mmol/L to 2 mmol/L.
The authors concluded that standardization of sodium and chloride across methods and matrices is not a simple task and emphasizes the need for a close collaboration between laboratory specialists and clinicians regarding education on pitfalls in laboratory medicine. The study was published on June 13, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Leiden University Medical Center
The first method, used in point-of-care blood gas analyzers, is direct potentiometry, which measures electrolyte activity in plasma without dilution. The second method, used in routine chemistry analyzers in central laboratories, is indirect ISE, which involves a pre-analytical serum or plasma dilution step.
Clinical biochemists at the Leiden University Medical Center (Leiden, The Netherlands) and their colleagues used anonymized laboratory results of patients admitted to the emergency room and intensive care unit, and demonstrated in four steps that this lack of interchangeability of sodium and chloride results can be attributed to differences in measurement principle, but also to analytical standardization issues of the blood gas analyzers.
The team extracted blood gas results performed on a RAPIDPoint 500 and routine chemistry performed on a Modular P800 sodium and chloride results for patients admitted to the emergency room of their hospital between June 1, 2014, and May 17, 2016.
The team investigated the effects of the introduction of the instrument factors in the blood gas analysers, by extracting blood gas and routine chemistry sodium and chloride results (with a maximum time of 1 hour between sample analysis) again for patients admitted to the emergency room of our hospital. This approach eliminated the systematic differences between blood gas and serum sodium for 92 emergency department patients, and reduced the mean difference in chloride to 1 mmol/L for 25 patients. The mean difference in sodium results between blood gas and serum for intensive care patients decreased from 4 mmol/L to 2 mmol/L.
The authors concluded that standardization of sodium and chloride across methods and matrices is not a simple task and emphasizes the need for a close collaboration between laboratory specialists and clinicians regarding education on pitfalls in laboratory medicine. The study was published on June 13, 2019, in the journal Practical Laboratory Medicine.
Related Links:
Leiden University Medical Center
Gold Member
Troponin T QC
Troponin T Quality Control
New
PSA Test
Humasis PSA Card
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
Latest Technology News
- Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
- Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
- Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
- Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
- Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
- Smartphones Could Diagnose Diseases Using Infrared Scans
- Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
- 3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
- POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
- Study Explores Impact of POC Testing on Future of Diagnostics
- Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
- Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears
- Lab-On-Chip Platform to Expedite Cancer Diagnoses
- Biosensing Platform Simultaneously Detects Vitamin C and SARS-CoV-2
- New Lens Method Analyzes Tears for Early Disease Detection
- FET-Based Sensors Pave Way for Portable Diagnostic Devices Capable of Detecting Multiple Diseases
Channels
Molecular Diagnostics
view channel
Groundbreaking Molecular Diagnostic Test Accurately Diagnoses Major Genetic Cause of COPD
Chronic obstructive pulmonary disease (COPD) and Alpha-1 Antitrypsin Deficiency (AATD) are both conditions that can cause breathing difficulties, but they differ in their origins and inheritance.... Read more
First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more
New Molecular Label to Help Develop Simpler and Faster Tuberculosis Tests
Tuberculosis (TB), the deadliest infectious disease globally, is responsible for infecting an estimated 10 million people each year and causing over 1 million deaths annually. While chest X-rays and molecular... Read more
Biomarker Discovery Paves Way for Blood Tests to Detect and Treat Osteoarthritis
The number of individuals affected by osteoarthritis is projected to exceed 1 billion by 2050. The primary risk factor for this common, often painful chronic joint condition is aging, and, like aging itself,... Read moreHematology
view channel
First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes
Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV
Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1.25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for... Read more
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Pathology
view channel
Groundbreaking Chest Pain Triage Algorithm to Transform Cardiac Care
Cardiovascular disease is responsible for a third of all deaths worldwide, and chest pain is the second most common reason for emergency department (ED) visits. With EDs often being some of the busiest... Read more
AI-Based Liquid Biopsy Approach to Revolutionize Brain Cancer Detection
Detecting brain cancers remains extremely challenging, with many patients only receiving a diagnosis at later stages after symptoms like headaches, seizures, or cognitive issues appear. Late-stage diagnoses... Read more
Technology
view channel
Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer
Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
